Streetbeat News

Stock Prices

EZGO

Jianhui Ye has reported a 6.77% stake in EZGO Technologies as of November 2, 2023, according to a 13D filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:16 pm

ICUI

ICU Medical reported Q3 earnings of $1.57 per share, beating the analyst consensus estimate of $1.38 by 13.77%. However, this is a 10.29% decrease from the same period last year. The company's quarterly sales were $553.31 million, missing the analyst consensus estimate of $565.75 million by 2.20%. This is a 7.45% decrease from the same period last year.

Portfolio Pulse from bharat@benzinga.com

November 06, 2023 | 9:16 pm

TRIP

TripAdvisor reported better-than-expected Q3 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:16 pm

VTYX

Shares of Ventyx Biosciences, Inc. are set to resume trading at 4:30 p.m. ET.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:14 pm

NXPI

NXP Semiconductors (NASDAQ:NXPI) reported Q3 earnings of $3.70 per share, beating the analyst consensus estimate of $3.59 by 3.06%. However, this is a 2.89% decrease from the same period last year. The company also reported quarterly sales of $3.43 billion, beating the analyst consensus estimate of $3.40 billion by 0.94%, but this is a 0.44% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:11 pm

AOSL

Alpha & Omega (NASDAQ:AOSL) reported Q1 2023 earnings of $0.33 per share, beating the analyst consensus estimate of $0.32 by 3.13%. However, this is a 72.5% decrease from the same period last year. The company also reported quarterly sales of $180.63 million, beating the estimate of $180.03 million by 0.33%, but this is a 13.36% decrease from the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 06, 2023 | 9:11 pm

CLOV

Clover Health Investments (NASDAQ:CLOV) reported Q3 sales of $482.07 million, missing the analyst consensus estimate of $494.60 million by 2.53 percent. This represents a 43.74 percent decrease compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:10 pm

HIMS

Hims & Hers Health, Inc. has announced a $50 million share repurchase program authorization. This move is typically seen as a sign of the company's confidence in its own stock and can potentially lead to a short-term increase in the stock price.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:06 pm

RNG

RingCentral has updated its FY23 Non-GAAP EPS forecast to $3.19-$3.20, which is higher than the estimated $3.15. The company also expects its total revenue to be between $2.198B-$2.205B, closely aligning with the estimated $2.2B.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:05 pm

FANG

Diamondback Energy (NASDAQ:FANG) reported Q3 earnings of $5.49 per share, beating the analyst consensus estimate of $4.92 by 11.59%. However, this is a 15.28% decrease from the same period last year. The company also reported quarterly sales of $2.34 billion, beating the estimate of $2.14 billion by 9.35%, but marking a 3.98% decrease from last year.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:05 pm